Syneos Health Hits 80-Plus Relative Strength Rating Benchmark

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Syneos Health (SYNH) cleared that benchmark Friday, with a jump from 78 to 82 Friday.


When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.

IBD’s proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock’s price movement over the last 52 weeks stacks up against all the other stocks in our database.

History reveals that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves.

Looking For Winning Stocks? Try This Simple Routine

Syneos Health is building a flat base with a 92.35 entry. See if the stock can clear the breakout price in volume at least 40% above average.

Taking a look at top and bottom line numbers, Syneos Health has posted rising EPS growth over the last two quarters. Top line growth has also risen over the same time frame.

The company earns the No. 11 rank among its peers in the Medical-Research Equipment/Services industry group. Charles River Labs International (CRL) and Iqvia (IQV) are also among the group’s highest-rated stocks.


Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Identify Bases And Buy Points With Pattern Recognition From MarketSmith

Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button
Native News Post